» Articles » PMID: 32766221

Stannic Oxide Nanoparticle Regulates Proliferation, Invasion, Apoptosis, and Oxidative Stress of Oral Cancer Cells

Overview
Date 2020 Aug 9
PMID 32766221
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To explore the effects of SnO nanoparticles (NPs) on proliferation, invasion, apoptosis, and oxidative stress of oral cancer.

Methods: SnO NPs were prepared and characterized. Oral cancer cell lines CAL-27 and SCC-9 were cultured . We detected the effects of various concentrations of SnO NPs (0, 5, 25, 50, 100, 200 μg/mL) on the proliferation of oral cancer cells, and observed the morphological changes, and measured the cells ability of migration, invasion and apoptosis condition, and the levels of oxidative stress were measured by detecting malondialdehyde (MDA) and reactive oxygen species (ROS). Besides, we also measured the changes of mRNA and protein levels of factors related to cell proliferation, migration, invasion, apoptosis, and oxidative stress.

Results: SnO NPs inhibited the proliferation of oral cancer cells in a concentration-dependent manner (all < 0.05). And SnO NPs treatment could reduce the migration and invasion ability of cells (all < 0.05), induce apoptosis, and those effects were better when treated for 48 h than 24 h (all < 0.05). And SnO NPs could induce oxidative stress in cells (all < 0.05). Besides, the concentrations of cyclin-D1, C-myc, matrix MMP-9, and MMP-2 in SnO NPs treated group was decreased (all < 0.05), and the expression levels of cleaved Caspase-3, cleaved Caspase-9, and Cytochrome C were increased (all < 0.05).

Conclusion: In the present study, we found that SnO NPs could play a cytotoxic role in oral cancer cells, and inhibit cell proliferation, migration, and invasion, and induce oxidative stress and apoptosis, which suggests that SnO NPs may have the effects of anti-oral cancer. However, a more in-depth study is needed to determine its roles.

Citing Articles

Illuminating new possibilities: Effects of copper oxide nanoparticles on gastrointestinal adenocarcinoma cells in hypoxic condition.

Talebian S, Shahnavaz B, Shakiba M, Rassouli F Heliyon. 2024; 10(10):e31414.

PMID: 38813193 PMC: 11133906. DOI: 10.1016/j.heliyon.2024.e31414.


-Driven Novel Biosynthesis of Tin Oxide Nanoparticles and Evaluation of Their Anti-aging, Cytotoxic, and Enzyme Inhibition Potential.

Rizwan M, Faisal S, Tariq M, Zafar S, Khan A, Ahmad F ACS Omega. 2023; 8(30):27439-27449.

PMID: 37546648 PMC: 10398689. DOI: 10.1021/acsomega.3c02932.


Pluronic-F-127-Passivated SnO Nanoparticles Derived by Using Root Extract: Synthesis, Characterization, and Anticancer Properties.

Alzahrani B, Elderdery A, Alzerwi N, Alsrhani A, Alsultan A, Rayzah M Plants (Basel). 2023; 12(9).

PMID: 37176818 PMC: 10181209. DOI: 10.3390/plants12091760.


Bacterial-mediated synthesis and characterization of copper oxide nanoparticles with antibacterial, antioxidant, and anticancer potentials.

Talebian S, Shahnavaz B, Nejabat M, Abolhassani Y, Rassouli F Front Bioeng Biotechnol. 2023; 11:1140010.

PMID: 36949885 PMC: 10025390. DOI: 10.3389/fbioe.2023.1140010.


Acute phase response following pulmonary exposure to soluble and insoluble metal oxide nanomaterials in mice.

Gutierrez C, Loizides C, Hafez I, Brostrom A, Wolff H, Szarek J Part Fibre Toxicol. 2023; 20(1):4.

PMID: 36650530 PMC: 9843849. DOI: 10.1186/s12989-023-00514-0.


References
1.
Xiong Q, Li Y, Zhou K, Chen P, Guo H, Chen L . Optimized fluorodendrimer-incorporated hybrid lipid-polymer nanoparticles for efficient siRNA delivery. Biomater Sci. 2020; 8(3):758-762. DOI: 10.1039/c9bm01738k. View

2.
Roopan S, Kumar S, Madhumitha G, Suthindhiran K . Biogenic-production of SnO2 nanoparticles and its cytotoxic effect against hepatocellular carcinoma cell line (HepG2). Appl Biochem Biotechnol. 2014; 175(3):1567-75. DOI: 10.1007/s12010-014-1381-5. View

3.
Chen J, Ding J, Xu W, Sun T, Xiao H, Zhuang X . Receptor and Microenvironment Dual-Recognizable Nanogel for Targeted Chemotherapy of Highly Metastatic Malignancy. Nano Lett. 2017; 17(7):4526-4533. DOI: 10.1021/acs.nanolett.7b02129. View

4.
Sun Y, Ma W, Yang Y, He M, Li A, Bai L . Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy. Asian J Pharm Sci. 2020; 14(6):581-594. PMC: 7032247. DOI: 10.1016/j.ajps.2019.04.005. View

5.
Shiga K, Tateda M, Katagiri K, Nakanome A, Ogawa T, Asada Y . Distinct features of second primary malignancies in head and neck cancer patients in Japan. Tohoku J Exp Med. 2011; 225(1):5-12. DOI: 10.1620/tjem.225.5. View